Trial
NCT01370044
Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Charite University, Berlin, Germany
Collaborators
—
Condition
Febrile Seizure
Intervention
Carbogen
Why stopped
results of interim analysis (not safety relevant)
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-26